Craft

Dyadic International

Stock Price

$1.1

2024-10-29

Market Capitalization

$32.1 M

2024-10-29

Revenue

$3.1 M

FY, 2025

Dyadic International Summary

Company Summary

Overview
Dyadic International is a biotech company focused on the development of the C1 technology to help bring biologic vaccines and drugs to the market. It is a fungal expression system for gene discovery, expression, and production of enzymes and other proteins.
Type
Public
Status
Active
Founded
1979
HQ
Jupiter, FL, US | view all locations
Website
https://www.dyadic.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Jupiter, FL HQ

    United States

    140 Intracoastal Pointe Dr #404

Dyadic International Financials

Summary Financials

Revenue (Q1, 2026)
$1.1M
Gross profit (Q1, 2026)
$319.1K
Net income (Q1, 2026)
($2.0M)
Cash (Q1, 2026)
$4.2M
EBIT (Q1, 2026)
($1.9M)
Enterprise value
$27.9M

Footer menu